KV Pharmaceutical - Press Releases


	About Us Corporate Officers Board of Directors Community Citizenship Our Brands Makena^® (hydroxyprogesterone caproate injection) Evamist^® (estradiol transdermal spray) Clindesse^® (clindamycin phosphate) Gynazole-1^® (Butoconazole Nitrate Vaginal Cream USP, 2%) Ask the Healthcare Professional Investor Relations SEC Filings News » Recent Headlines Press Releases Conference Calls Media Contacts Upcoming Investor Events Investor FAQs Investor Contacts Corporate Governance Corporate Officers Board of Directors Research & Development Update on Ongoing Makena^® (hydroxyprogesterone caproate injection) Research

6/19/2013 1:22:13 AM

KVPHQ:

KVPBQ:


	Press Releases

Press Releases

Select Year

Date
January 24, 2013	Ther-Rx Corporation and Perrigo Company Announce the Availability of Gynazole-1® (Butoconazole Nitrate Vaginal Cream USP, 2%) for Prescribing

Home | Contact Us | Site Directory | Legal/Privacy | Compliance Program

©2013 KV Pharmaceutical Company. All Rights Reserved.